Related Experiment Videos
Magnetic resonance spectroscopy: imaging axonal damage in MS
1MRS Unit, Montreal Neurological Institute, Quebec, Canada. doug@mrs.mni.mcgill.ca
Journal of Neuroimmunology
|July 30, 1999
Summary
Multiple sclerosis involves significant axonal damage, not just demyelination. This damage, found in lesions and normal white matter, worsens over time and links to disability, suggesting it causes chronic MS symptoms.
Area of Science:
- Neuroscience
- Neurology
- Biomarkers
Background:
- Multiple sclerosis (MS) is characterized by demyelination and axonal damage.
- Axonal damage is a key pathological feature in MS, impacting both lesions and normal-appearing white matter.
- The extent of axonal damage correlates with clinical disability in MS patients.
Purpose of the Study:
- To investigate the role of axonal damage in multiple sclerosis pathophysiology.
- To explore the relationship between axonal damage, demyelination, and clinical disability in MS.
- To test the hypothesis that axonal damage contributes significantly to chronic disability in MS.
Main Methods:
- Utilized magnetic resonance spectroscopy (MRS) to measure N-acetylaspartate (NAA) as an axonal marker.
- Assessed axonal damage in both MS lesions and normal-appearing white matter.
- Correlated axonal damage measurements with clinical disability assessments.
Main Results:
- Substantial axonal damage was observed in multiple sclerosis patients, co-occurring with demyelination.
- Axonal damage was detected in both MS lesions and normal-appearing white matter.
- Progressive axonal damage over time was observed, correlating with increased clinical disability.
Conclusions:
- Axonal damage is a significant pathological process in multiple sclerosis, present beyond demyelinated areas.
- The progression of axonal damage is linked to the accrual of chronic disability in MS.
- Axonal damage, potentially compensated by sodium channel adaptations, is hypothesized to be a primary driver of long-term MS-related disability.